Literature DB >> 19679891

Short-term outcomes of mothers and infants exposed to antenatal amphetamines.

J Oei1, M E Abdel-Latif, R Clark, F Craig, K Lui.   

Abstract

AIM: To determine the short-term outcomes of newborn infants and mothers exposed to antenatal amphetamines in the state of New South Wales and the Australian Capital Territory during 2004.
METHODS: Amphetamine exposure was determined retrospectively using ICD-10 AM morbidity code searches of hospital medical records and from records of local drug and alcohol services. Records were reviewed on site. All public hospitals (n = 101) with obstetric services were included.
RESULTS: Amphetamines were used by 200 (22.9%) of the 871 identified drug-using mothers. Most women (182, 91%) injected amphetamines intravenously. Compared with the other 669 drug users, amphetamine-using mothers were significantly more likely to use multiple classes of drugs (45.0% vs 7.8%), be subject to domestic violence (32.1% vs 17.5%), be homeless (14.8% vs 4.9%) and be involved with correctional services (19.8% vs 9.7%). The incidence of comorbid psychiatric illnesses were significantly higher (57.4% vs 41.7%) and their infants were more likely to be preterm (29.5% vs 20.4%), notified as children at risk (67.0% vs 32.8%), fostered before hospital discharge (14.5% vs 5.5%) and less likely to be breastfed (27.0% vs 41.6%).
CONCLUSIONS: Amphetamine-exposed mothers and infants in public hospitals of NSW and the ACT are at significantly higher risk of adverse social and perinatal outcomes even when compared with mothers and infants exposed to other drugs of dependency. Increased vigilance for amphetamine exposure is recommended due to a high prevalence of use, especially in Australia, as a recreational drug.

Entities:  

Mesh:

Year:  2009        PMID: 19679891     DOI: 10.1136/adc.2008.157305

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  9 in total

1.  Testing the programming of temperament and psychopathology in two independent samples of children with prenatal substance exposure.

Authors:  Betty Lin; Brendan D Ostlund; Elisabeth Conradt; Linda L Lagasse; Barry M Lester
Journal:  Dev Psychopathol       Date:  2018-08

2.  Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats.

Authors:  Gonzalo Flores; María de Jesús Gómez-Villalobos; Leonardo Rodríguez-Sosa
Journal:  Neurochem Res       Date:  2011-05-25       Impact factor: 3.996

3.  Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Authors:  Rizwan Shah; Sabrina D Diaz; Amelia Arria; Linda L LaGasse; Chris Derauf; Elana Newman; Lynne M Smith; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Mary B Roberts; Charles Neal; Barry M Lester
Journal:  Am J Perinatol       Date:  2012-03-07       Impact factor: 1.862

4.  The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study.

Authors:  Zeina N Kiblawi; Lynne M Smith; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn Huestis; Sheri DellaGrotta; Lynne M Dansereau; Charles Neal; Barry Lester
Journal:  J Dev Behav Pediatr       Date:  2013-01       Impact factor: 2.225

5.  Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand.

Authors:  Trecia A Wouldes; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne M Smith; Amelia M Arria; Marilyn A Huestis; Sheri DellaGrotta; Tara Wilcox; Charles R Neal; Barry M Lester
Journal:  Drug Alcohol Depend       Date:  2012-07-11       Impact factor: 4.492

Review 6.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

7.  Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study.

Authors:  Zeina N Kiblawi; Lynne M Smith; Sabrina D Diaz; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri DellaGrotta; Lynne M Dansereau; Charles Neal; Barry Lester
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

8.  Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.

Authors:  Alison S Poulton; Bruce Armstrong; Ralph K Nanan
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

9.  Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.

Authors:  Jean Twomey; Linda LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne Smith; Amelia Arria; Marilyn Huestis; Sheri DellaGrotta; Mary Roberts; Lynne Dansereau; Charles Neal; Barry Lester
Journal:  Am J Orthopsychiatry       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.